Back to Jane Street Group, LLC Jane Street Group, LLC

NTLANTLA

Showing 8 of 25 quarters

Position history for Jane Street Group, LLCJane Street Group, LLC's holdings in Intellia Therapeutics, Inc.

Yes. Jane Street Group holds 13,350 shares of NTLA (Intellia Therapeutics), worth $225,882, as of its Q2 2026 13F filing. It reduced the position by 371,607 shares (-96.5%) from Q1 2026. Jane Street Group has held NTLA since Q2 2020, across 25 quarterly 13F filings.

Current Value

$225,882

Current Shares

13,350

Total Value Change

-$4.6M

Total Shares Change

-222,777

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
13,350
-96.5%
$225,8820.0%$16.92
0
2026-Q1
Increased
384,957
+15.8%
$4.9M0.0%$12.82
31
2025-Q4
Increased
332,471
+66.2%
$3M0.0%$8.99
39
2025-Q3
Decreased
200,099
-6.0%
$3.5M0.0%$17.27
0
2025-Q2
Increased
212,830
+43.8%
$2M0.0%$9.38
35
2025-Q1
Decreased
148,035
-42.0%
$1.1M0.0%$7.11
0
2024-Q4
Increased
255,256
+8.1%
$3M0.0%$11.66
29
2024-Q3
Decreased
236,127
-3.8%
$4.9M0.0%$20.55
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used